Last reviewed · How we verify

amantadine sulfate — Competitive Intelligence Brief

amantadine sulfate (amantadine sulfate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiviral / Dopamine agonist. Area: Virology; Neurology.

marketed Antiviral / Dopamine agonist Influenza A M2 ion channel; dopamine system (mechanism not fully elucidated) Virology; Neurology Small molecule Live · refreshed every 30 min

Target snapshot

amantadine sulfate (amantadine sulfate) — Jee-Young Lee. Amantadine blocks the M2 ion channel of influenza A virus, preventing viral uncoating and replication, and also increases dopamine release in the central nervous system.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
amantadine sulfate TARGET amantadine sulfate Jee-Young Lee marketed Antiviral / Dopamine agonist Influenza A M2 ion channel; dopamine system (mechanism not fully elucidated)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiviral / Dopamine agonist class)

  1. Jee-Young Lee · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). amantadine sulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/amantadine-sulfate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: